Free Prescriptions Offered to Indigent Patients
RIDGEFIELD, Conn. - The Boehringer Ingelheim Cares Foundation will being a new patient assistance program, providing prescription medications to Americans who cannot afford them.
Officials say the program is designed to specifically help older Americans, and those suffering from the AIDS virus by virtue of the drugs manufactured by Boehringer Ingelheim Pharmaceuticals.
"As a maker of life-saving medicines, we want to help patients who cannot afford their medicines," says foundation president Pamela S. DeMala. "We've developed a program to give those patients free medication, and to get the drugs into patients' hands quickly and efficiently.
To qualify, patients must lack prescription coverage under a private, government or employee insurance plan; be ineligible for prescription assistance through Medicaid; have an annual income equal to or lower than 200 percent of the Federal Poverty Level, which would be $18,00 for a family of four; for those in need of HIV/AIDS drug Viramune, they must have an annual income equal or lower than $25,000; and they must be a citizen of the United States.
There are no co-payments or fees charged for participation and no membership cared will be required.
One-page applications are available at: 800-556-8317.
For more information, visit: http://us.boehringer-ingelheim.com
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
